125 related articles for article (PubMed ID: 34156092)
1. The molecular landscape of well differentiated retroperitoneal liposarcoma.
Tyler R; Dilworth MP; James J; Blakeway D; Stockton JD; Morton DG; Taniere P; Gourevitch D; Desai A; Beggs AD
J Pathol; 2021 Oct; 255(2):132-140. PubMed ID: 34156092
[TBL] [Abstract][Full Text] [Related]
2. Distinct mdm2/p53 expression patterns in liposarcoma subgroups: implications for different pathogenetic mechanisms.
Pilotti S; Della Torre G; Lavarino C; Di Palma S; Sozzi G; Minoletti F; Rao S; Pasquini G; Azzarelli A; Rilke F; Pierotti MA
J Pathol; 1997 Jan; 181(1):14-24. PubMed ID: 9071998
[TBL] [Abstract][Full Text] [Related]
3. A review of retroperitoneal liposarcoma genomics.
Tyler R; Wanigasooriya K; Taniere P; Almond M; Ford S; Desai A; Beggs A
Cancer Treat Rev; 2020 Jun; 86():102013. PubMed ID: 32278233
[TBL] [Abstract][Full Text] [Related]
4. Complex composition and co-amplification of SAS and MDM2 in ring and giant rod marker chromosomes in well-differentiated liposarcoma.
Pedeutour F; Suijkerbuijk RF; Forus A; Van Gaal J; Van de Klundert W; Coindre JM; Nicolo G; Collin F; Van Haelst U; Huffermann K
Genes Chromosomes Cancer; 1994 Jun; 10(2):85-94. PubMed ID: 7520271
[TBL] [Abstract][Full Text] [Related]
5. Retroperitoneal liposarcoma and craniosynostosis: possible genomic relationship, case report, and literature review.
Sguinzi RM; Aissaoui S; Genevay-Infante M; Breguet R; Charbonnet P; Francis K; Kini R; Bühler L
Funct Integr Genomics; 2022 Dec; 23(1):8. PubMed ID: 36538187
[TBL] [Abstract][Full Text] [Related]
6. Molecular Characterization of a Rare Dedifferentiated Liposarcoma With Rhabdomyosarcomatous Differentiation in a 24 Year Old.
Olson N; Gularte-Mérida R; Selenica P; Da Cruz Paula A; Alemar B; Weigelt B; Lefferts J; Linos K
Int J Surg Pathol; 2020 Jun; 28(4):454-463. PubMed ID: 31801397
[No Abstract] [Full Text] [Related]
7. Primary retroperitoneal myxoid/round cell liposarcoma is a nonexisting disease: an immunohistochemical and molecular biological analysis.
de Vreeze RS; de Jong D; Tielen IH; Ruijter HJ; Nederlof PM; Haas RL; van Coevorden F
Mod Pathol; 2009 Feb; 22(2):223-31. PubMed ID: 18820664
[TBL] [Abstract][Full Text] [Related]
8. Most malignant fibrous histiocytomas developed in the retroperitoneum are dedifferentiated liposarcomas: a review of 25 cases initially diagnosed as malignant fibrous histiocytoma.
Coindre JM; Mariani O; Chibon F; Mairal A; De Saint Aubain Somerhausen N; Favre-Guillevin E; Bui NB; Stoeckle E; Hostein I; Aurias A
Mod Pathol; 2003 Mar; 16(3):256-62. PubMed ID: 12640106
[TBL] [Abstract][Full Text] [Related]
9. Genomic landscape of liposarcoma.
Kanojia D; Nagata Y; Garg M; Lee DH; Sato A; Yoshida K; Sato Y; Sanada M; Mayakonda A; Bartenhagen C; Klein HU; Doan NB; Said JW; Mohith S; Gunasekar S; Shiraishi Y; Chiba K; Tanaka H; Miyano S; Myklebost O; Yang H; Dugas M; Meza-Zepeda LA; Silberman AW; Forscher C; Tyner JW; Ogawa S; Koeffler HP
Oncotarget; 2015 Dec; 6(40):42429-44. PubMed ID: 26643872
[TBL] [Abstract][Full Text] [Related]
10. Similarity in genetic alterations between paired well-differentiated and dedifferentiated components of dedifferentiated liposarcoma.
Horvai AE; DeVries S; Roy R; O'Donnell RJ; Waldman F
Mod Pathol; 2009 Nov; 22(11):1477-88. PubMed ID: 19734852
[TBL] [Abstract][Full Text] [Related]
11. Myogenic differentiation and histologic grading are major prognostic determinants in retroperitoneal liposarcoma.
Gronchi A; Collini P; Miceli R; Valeri B; Renne SL; Dagrada G; Fiore M; Sanfilippo R; Barisella M; Colombo C; Morosi C; Stacchiotti S; Casali PG; Dei Tos AP; Pilotti S
Am J Surg Pathol; 2015 Mar; 39(3):383-93. PubMed ID: 25581729
[TBL] [Abstract][Full Text] [Related]
12. Retroperitoneal liposarcoma with combined well-differentiated and myxoid malignant fibrous histiocytoma-like myxoid areas.
Hisaoka M; Morimitsu Y; Hashimoto H; Ishida T; Mukai H; Satoh H; Motoi T; Machinami R
Am J Surg Pathol; 1999 Dec; 23(12):1480-92. PubMed ID: 10584701
[TBL] [Abstract][Full Text] [Related]
13. Liposarcomatous differentiation in malignant phyllodes tumours is unassociated with MDM2 or CDK4 amplification.
Lyle PL; Bridge JA; Simpson JF; Cates JM; Sanders ME
Histopathology; 2016 Jun; 68(7):1040-5. PubMed ID: 26542423
[TBL] [Abstract][Full Text] [Related]
14. [Giant lipomas or retroperitoneal liposarcomas? Controversies in their diagnosis and treatment].
Fernández Hernández JÁ; Navarro-Barrios Á; Gil Vázquez PJ; Gil JE; Varona Garcíal L; López Motos D; Fernández Selles C; Nieto G; Frutos Bernal MD; Torres Salmerón G; Soria Cogollos T
Rev Esp Patol; 2021; 54(2):75-84. PubMed ID: 33726894
[TBL] [Abstract][Full Text] [Related]
15. Association of FPGS genetic polymorphisms with primary retroperitoneal liposarcoma.
Miao C; Liu D; Zhang F; Wang Y; Zhang Y; Yu J; Zhang Z; Liu G; Li B; Liu X; Luo C
Sci Rep; 2015 Mar; 5():9079. PubMed ID: 25765001
[TBL] [Abstract][Full Text] [Related]
16. Update on genomic and molecular landscapes of well-differentiated liposarcoma and dedifferentiated liposarcoma.
Lu J; Wood D; Ingley E; Koks S; Wong D
Mol Biol Rep; 2021 Apr; 48(4):3637-3647. PubMed ID: 33893924
[TBL] [Abstract][Full Text] [Related]
17. Well-differentiated lipomatous neoplasms with p53 alterations: a clinicopathological and molecular study of eight cases with features of atypical pleomorphic lipomatous tumour.
Hammer PM; Kunder CA; Howitt BE; Charville GW
Histopathology; 2022 Mar; 80(4):656-664. PubMed ID: 34725851
[TBL] [Abstract][Full Text] [Related]
18. Integrated genomic and transcriptomic analysis revealed mutation patterns of de-differentiated liposarcoma and leiomyosarcoma.
Liu W; Tong H; Zhang C; Zhuang R; Guo H; Lv C; Yang H; Lin Q; Guo X; Wang Z; Wang Y; Shen F; Wang S; Dai C; Wang G; Liu J; Lu W; Zhang Y; Zhou Y
BMC Cancer; 2020 Oct; 20(1):1035. PubMed ID: 33115433
[TBL] [Abstract][Full Text] [Related]
19. Amplification of FRS2 in atypical lipomatous tumour/well-differentiated liposarcoma and de-differentiated liposarcoma: a clinicopathological and genetic study of 146 cases.
Jing W; Lan T; Chen H; Zhang Z; Chen M; Peng R; He X; Zhang H
Histopathology; 2018 Jun; 72(7):1145-1155. PubMed ID: 29368794
[TBL] [Abstract][Full Text] [Related]
20. A novel long noncoding RNA PILRLS promote proliferation through TCL1A by activing MDM2 in Retroperitoneal liposarcoma.
Shao Y; Zhang Y; Hou Y; Tong H; Zhuang R; Ji Z; Wang B; Zhou Y; Lu W
Oncotarget; 2017 Feb; 8(8):13971-13978. PubMed ID: 28129655
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]